You have 9 free searches left this month | for more free features.

palmar-plantar erythrodysesthesia

Showing 1 - 25 of 1,908

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Palmar-Plantar Erythrodysesthesia, Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy Trial in Kuching (Moisturising

Recruiting
  • Palmar-Plantar Erythrodysesthesia
  • Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
  • Moisturising cream containing palm-oil derived vitamin E concentrate and urea cream
  • +2 more
  • Kuching, Sarawak, Malaysia
    Sarawak General Hospital
Jul 2, 2023

Erythrodysesthesia Syndrome Trial (Photobiomodulation, Moisturizer)

Not yet recruiting
  • Erythrodysesthesia Syndrome
  • Photobiomodulation
  • Moisturizer
  • (no location specified)
Dec 24, 2022

Breast Cancer, Chemotherapeutic Agent Toxicity, Palmar-plantar Erythrodysesthesia Trial in San Francisco (Nicotine patch)

Terminated
  • Breast Cancer
  • +2 more
  • Nicotine patch
  • San Francisco, California
    University of California, San Francisco
Sep 11, 2020

Palmar-plantar Erythrodysesthesia (PPE) Trial in Nicosia (Henna, Placebo)

Completed
  • Palmar-plantar Erythrodysesthesia (PPE)
  • Nicosia, Cyprus
    American Medical Centre
Oct 23, 2019

Palmar or Plantar Warts Trial in Paris (Vaccination)

Recruiting
  • Palmar or Plantar Warts
  • Vaccination
  • Paris, France
    Hospital Cochin
Sep 6, 2022

Breast Cancer, Palmar-plantar Erythrodysesthesia Trial in Switzerland (antiperspirant cream F511, pegylated liposomal

Completed
  • Breast Cancer
  • Palmar-plantar Erythrodysesthesia
  • antiperspirant cream F511
  • pegylated liposomal doxorubicin hydrochloride
  • Aarau, Switzerland
  • +14 more
May 14, 2019

Palmar-Plantar Erythrodysesthesia, Breast Cancer Trial in United States (Cream, 0.1% Uracil Cream)

Completed
  • Palmar-Plantar Erythrodysesthesia
  • Breast Cancer
  • Birmingham, Alabama
  • +5 more
Oct 5, 2019

Hand and Foot Syndrome Trial in Cairo ((CARBAMIDE®), (VOLTAREN®) Emulgel 1%)

Recruiting
  • Hand and Foot Syndrome
  • Cairo, Egypt
    KASR ALAINY Center of Oncology and Nuclear medicine
Jan 26, 2023

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer
Sep 15, 2022

Hepatocellular Carcinoma Trial in Barcelona, Madrid, Oviedo (Cabozantinib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Barcelona, Spain
  • +5 more
Jul 7, 2022

Spasticity/Paresis, Cerebral Palsy Trial (device, drug, other, behavioral)

Not yet recruiting
  • Spasticity/Paresis
  • Cerebral Palsy
  • ESWT
  • +4 more
  • (no location specified)
Nov 15, 2023

Smart-Phone App for Advanced Renal Cell Carcinoma Undergoing

Recruiting
  • Renal Cell Carcinoma Stage IV
  • mHealth Smart Phone Application
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 11, 2022

Palmar-Plantar Erythrodysesthesia Trial in Limassol, Nicosia (Vitamin B6 cream, Placebo Vitamin B6 cream)

Completed
  • Palmar-Plantar Erythrodysesthesia
  • Vitamin B6 cream
  • Placebo Vitamin B6 cream
  • Limassol, Cyprus
  • +1 more
Aug 6, 2018

Hand-foot Syndrome Trial in Shanghai (Gel containing Acetylated Natural Nucleotides, Vehicle Gel)

Recruiting
  • Hand-foot Syndrome
  • Gel containing Acetylated Natural Nucleotides
  • Vehicle Gel
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Dec 8, 2021

Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in

Completed
  • Pleomorphic Rhabdomyosarcoma
  • +3 more
  • Epirubicin Hydrochloride
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 23, 2022

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Hand-Foot Skin Reaction (HFSR) Trial in United States (OQL011, Vehicle Ointment)

Recruiting
  • Hand-Foot Skin Reaction (HFSR)
  • Whittier, California
  • +32 more
Jan 16, 2023

Hand Foot Skin Reaction Trial in Chicago (Sildenafil)

Completed
  • Hand Foot Skin Reaction
  • Chicago, Illinois
  • +1 more
Oct 29, 2021

Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)

Completed
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 29, 2021

Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor

Completed
  • Metastatic or Unresectable Solid Tumor Malignancy
  • Fort Myers, Florida
  • +2 more
Feb 15, 2022

Advanced Solid Tumors Trial in Switzerland (TLD-1, Caelyx)

Recruiting
  • Advanced Solid Tumors
  • Bellinzona, Switzerland
  • +3 more
Dec 24, 2021

Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

Completed
  • Malignant Adrenal Gland Pheochromocytoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 28, 2022

Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • Norfolk, Nebraska
  • +2 more
Aug 10, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)

Completed
  • Pancreas Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 20, 2022